What increases the risk of graft versus host disease (GVHD) following hematopoietic cell transplantation (HCT) for aplastic anemia?

Updated: Jan 29, 2021
  • Author: Sameer Bakhshi, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The occurrence of GVHD as a complication of HCT is positively correlated with increasing age of the patient. Grafts depleted of T cells reduce the risk of GVHD but increase the risk of graft failure. The addition of cyclosporine along with methotrexate is the standard GVHD approach for matched siblings. [75] However, very few comparative data exist, and no data have reported an alternative approach to be superior to this regimen.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!